FDA On the Fence About OTC Birth Control

May 9th, 2023|Categories: Featured, Industry News|Tags: , , , , |

The US Food and Drug Administration (FDA) recently met to discuss whether to approve Opill, Perrigo’s hormonal contraceptive, for over-the-counter (OTC) use. Although reproductive rights advocates contend that the move would expand access to contraceptives to people who don’t have a primary care clinician, some religious advocates and committee members argued against it.

Go to Top